2022 Speakers | World Medical Innovation Forum - Gene and Cell Therapy
WMIF Main Site

2022 Speakers

Forum speakers include CEOs of leading companies in the GCT and biotech fields, investors, entrepreneurs, Harvard clinicians and scientists, government officials and other key influencers.

Laura Aguilar, MD, PhD
CMO, Candel Therapeutics

Albert Bourla, PhD
CEO, Pfizer 

Robert Bradway
CEO, Amgen

Pablo Cagnoni, MD
CEO, Rubius Therapeutics

Marc Casper
CEO, Thermo Fisher Scientific

Rachel Haurwitz, PhD
President & CEO, Caribou Biosciences

Rosana Kappeler, MD, PhD
Co-founder, President and CEO, ROME Therapeutics

Sekar Kathiresan, MD
CEO, Verve Therapeutics

Anne Klibanski, MD
CEO, Mass General Brigham

Stephen Knight, MD
President & Managing Partner, F-Prime Capital

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, FDA

Luigi Naldini, MD, PhD
Director, San Raffaele Telethon Institute for Gene Therapy, San Rafael School of Medicine

Andrew Plump, MD, PhD
President, R&D, Takeda

John Reed, MD, PhD
EVP, Global Head of R&D, Sanofi

Issi Rozen
Venture Partner, Google Ventures

Ned Sharpless, MD
Director, National Cancer Institute

Richard Young, PhD
Professor of Biology, MIT

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA